Literature DB >> 30177366

Criteria for ECG detection of acute myocardial ischemia: Sensitivity versus specificity.

John J Wang1, Olle Pahlm2, James W Warren3, John L Sapp3, B Milan Horáček3.   

Abstract

BACKGROUND: Criteria for electrocardiographic detection of acute myocardial ischemia recommended by the Consensus Document of ESC/ACCF/AHA/WHF consist of two parts: The ST elevation myocardial infarction (STEMI) criteria based on ST elevation (ST↑) in 10 pairs of contiguous leads and the other on ST depression (ST↓) in the same 10 contiguous pairs. Our aim was to assess sensitivity (SE) and specificity (SP) of these criteria-and to seek their possible improvements-in three databases of 12‑lead ECGs.
METHODS: We used (1) STAFF III data of controlled ischemic episodes recorded from 99 patients (pts) during percutaneous coronary intervention (PCI) involving either left anterior descending (LAD) coronary artery, right coronary artery (RCA), or left circumflex (LCx) coronary artery. (2) Data from the University of Glasgow for 58 pts with acute myocardial infarction (AMI) and 58 pts without AMI, as confirmed by MRI. (3) Data from Lund University retrieved from a centralized ECG management system for 100 pts with various pathological ST changes-other than acute coronary occlusion-including ventricular pre-excitation, acute pericarditis, early repolarization syndrome, left ventricular hypertrophy, and left bundle branch block. ST measurements at J-point in ECGs of all 315 pts were obtained automatically on the averaged beat with manual review and the recommended criteria as well as their proposed modifications, were applied. Performance measures included SE, SP, positive predictive value (PPV), and benefit-to-harm ratio (BHR), defined as the ratio of true-positive vs. false-positive detections.
RESULTS: We found that the SE of widely-used STEMI criteria can be indeed improved by the additional ST↓ criteria, but at the cost of markedly decreased SP. In contrast, using ST↑ in only 3 additional contiguous pairs of leads (STEMI13) can boost SE without any loss of SP. In the STAFF III database, SE/SP/PPV were 56/98/97% for the STEMI, 79/79/79% for the STEMI with added ST↓ and 67/97/96% for the STEMI13. In the Glasgow database, corresponding SE/SP/PPV were 43/98/96%, 84/90/89%, and 55/98/97%. For the Lund database, SP was 56% for the STEMI, 24% for the STEMI with ST↓, and 56% for the STEMI13.
CONCLUSION: Current recommended criteria for detecting acute myocardial ischemia, involving ST↓, boost SE of widely-used STEMI criteria, at the cost of SP. To keep the SP high, we propose either the adjustment of threshold for the added ST↓ criteria or a selective use of ST↓ only in contiguous leads V2 and V3 plus ST↑ in lead pairs (aVL, -III) and (III, -aVL).
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemia detection; Electrocardiographic monitoring; Non-ischemic ST-segment deviation; STEMI criteria

Mesh:

Year:  2018        PMID: 30177366     DOI: 10.1016/j.jelectrocard.2018.08.018

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  6 in total

1.  A telediagnosis assistance system for multiple-lead electrocardiography.

Authors:  Paulo César Lucena Bentes; Jurandir Nadal
Journal:  Phys Eng Sci Med       Date:  2021-04-02

2.  Performance and limitations of automated ECG interpretation statements in patients with suspected acute coronary syndrome.

Authors:  Ziad Faramand; Stephanie Helman; Abdullah Ahmad; Christian Martin-Gill; Clifton Callaway; Samir Saba; Richard E Gregg; John Wang; Salah Al-Zaiti
Journal:  J Electrocardiol       Date:  2021-08-18       Impact factor: 1.438

3.  The Importance of the 15-lead Versus 12-lead ECG Recordings in the Diagnosis and Treatment of Right Ventricle and Left Ventricle Posterior and Lateral Wall Acute Myocardial Infarctions.

Authors:  Ioannis Vogiatzis; Efstathios Koulouris; Antonios Ioannidis; Evangelos Sdogkos; Maria Pliatsika; Pavlos Roditis; Markos Goumenakis
Journal:  Acta Inform Med       Date:  2019-03

Review 4.  Biomarkers in acute myocardial infarction: current perspectives.

Authors:  Suleyman Aydin; Kader Ugur; Suna Aydin; İbrahim Sahin; Meltem Yardim
Journal:  Vasc Health Risk Manag       Date:  2019-01-17

5.  Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.

Authors:  Zongying Yu; Jie Song; Li Cheng; Shasha Li; Qun Lu; Yafeng Zhang; Xiaoci Lin; Dadong Liu
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

Review 6.  Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.

Authors:  Ioan Tilea; Andreea Varga; Razvan Constantin Serban
Journal:  Diagnostics (Basel)       Date:  2021-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.